James Millonig, Ph.D., Associate Professor, Center for Advanced Biotechnology and Medicine, Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School.

CABM Researchers are Honored for Their Various Research Patent Achievements

CABM researchers Drs. James Millonig, Kalyan Das, Rong Xiao, and graduate fellow Patrick Nosker were recently recognized for their various collaborative research patents.

Dr. James Millonig has been awarded the 2012 Thomas Alva Edison Patent Award by the Research and Development Council of New Jersey. The award was granted for “Compositions and Methods of Diagnosing Autism” (U.S. Patent 7,629,123). The patent’s research has, in part, led to the launch of the ARISK™ Autism Risk Assessment Test by establishing an association between ENGRAILED HOMEOBOX 2 transcription factor (EN2) and susceptibility for autism and related disorders. Dr. Millonig will be will be recognized in the medical diagnostic category, along with co-inventors Linda Brzustowicz, MD, professor of genetics at Rutgers, and Neda Gharani, PhD, senior research scientist at the Coriell Institute. The Edison Patent Award is given to key individuals honoring their contributions in research and development leadership, education, and science and technology. The Research and Development Council of New Jersey is a nonprofit organization dedicated to cultivating an environment that supports the advancement of research and development in New Jersey. The Council's membership includes representatives from academia, government and industry.

Drs. Kalyan Das and Rong Xiao were honored by the Rutgers University Office of Technology Commercialization at its 2012 Rutgers Patent Awards reception for their work on "Influenza A Virus Vaccines and Inhibitors" (U.S. Patent 7,709,190). Drs. Das and Xiao, along with CABM resident faculty members Gaetano Montelione and Eddy Arnold, have outlined processes for discovering, designing, and optimizing small molecule inhibitors of influenza A (avian flu) viruses and creating attenuated influenza virus strains suitable for avian and human flu vaccine development.

Graduate fellow Patrick Nosker was also recognized by the Rutgers University Office of Technology Commercialization for his development of an effective, safe, and inert flame retardant coating designed to protect thermoplastics (U.S. Patents 7,851,536 and 8,048,486). Nosker was also awarded a patent for "Compositions and Methods for the Protection of Substrates from Heat Flux and Fire" (U.S. Patent 7,955,996). The patent outlines a protective coating or paint used to protect any substrate from heat and fire and is designed to be flexible and retain adhesion below 75 degrees centigrade. The material was originally designed for the United States Department of Defense. Both inventions are currently licensed worldwide.

For more information on the aforementioned patents, please visit the United States Patent and Trademark Office site.